NASDAQ:XLO
Xilio Therapeutics, Inc. Stock Insider Trading
$1.18
+0.130 (+12.38%)
At Close: May 03, 2024
| Date | Action | Amount | Person | Type |
|---|---|---|---|---|
| May 01, 2024 | Buy | 59 333 | Luptakova Katarina | Stock Option (right to buy) |
| May 01, 2024 | Buy | 20 000 | Brennan Kevin M. | Stock Option (right to buy) |
| May 01, 2024 | Buy | 208 000 | Frankenfield Christopher James | Stock Option (right to buy) |
| May 01, 2024 | Buy | 474 000 | Russo Rene | Stock Option (right to buy) |
| Apr 02, 2024 | Buy | 485 250 | Gilead Sciences, Inc. | Common Stock |
| Apr 02, 2024 | Buy | 3 882 450 | Gilead Sciences, Inc. | Prefunded Warrants (right to buy) |
| Mar 27, 2024 | Buy | 0 | Gilead Sciences, Inc. | Common Stock |
| Feb 08, 2024 | Sell | 733 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Feb 08, 2024 | Sell | 267 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Jan 12, 2024 | Sell | 1 540 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Jan 12, 2024 | Sell | 560 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Jan 11, 2024 | Sell | 1 566 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Jan 11, 2024 | Sell | 569 | Atlas Venture Fund Xi, L.p. | Common Stock |
| Jan 01, 2024 | Buy | 77 500 | Frankenfield Christopher James | Restricted Stock Units |
| Jan 01, 2024 | Buy | 66 500 | Luptakova Katarina | Restricted Stock Units |
| Jan 01, 2024 | Buy | 20 000 | Brennan Kevin M. | Restricted Stock Units |
| Jan 01, 2024 | Buy | 177 000 | Russo Rene | Restricted Stock Units |
| Sep 05, 2023 | Buy | 106 000 | Luptakova Katarina | Stock Option (Right to Buy) |
| Sep 05, 2023 | Buy | 44 210 | Luptakova Katarina | Stock Option (right to buy) |
| Sep 05, 2023 | Buy | 15 000 | Luptakova Katarina | Stock Option (right to buy) |
| Sep 05, 2023 | Buy | 35 000 | Luptakova Katarina | Stock Option (right to buy) |
| Sep 05, 2023 | Buy | 25 000 | Luptakova Katarina | Stock Option (right to buy) |
| Aug 16, 2023 | Buy | 700 000 | Russo Rene | Stock Option (right to buy) |
| Aug 16, 2023 | Buy | 300 000 | Frankenfield Christopher James | Stock Option (right to buy) |
| Aug 16, 2023 | Buy | 25 000 | Brennan Kevin M. | Stock Option (right to buy) |
| Aug 16, 2023 | Buy | 136 500 | Huber Martin H. Jr. | Stock Option (right to buy) |
| Aug 03, 2023 | Buy | 150 000 | Frankenfield Christopher James | Stock Option (Right to Buy) |
| Aug 03, 2023 | Buy | 23 786 | Frankenfield Christopher James | Stock Option (right to buy) |
| Aug 03, 2023 | Buy | 37 296 | Frankenfield Christopher James | Stock Option (right to buy) |
| Aug 03, 2023 | Buy | 45 000 | Frankenfield Christopher James | Stock Option (right to buy) |
| Aug 03, 2023 | Buy | 20 000 | Frankenfield Christopher James | Stock Option (right to buy) |
| Aug 03, 2023 | Buy | 117 000 | Frankenfield Christopher James | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Ross Robert W. | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Heyman Tomas J. | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Xu Yuan | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Bonstein Sara | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Rossi Christina | Stock Option (right to buy) |
| Jun 12, 2023 | Buy | 13 200 | Clancy Paul J | Stock Option (right to buy) |
| Apr 01, 2023 | Buy | 55 000 | Brennan Kevin M. | Stock Option (right to buy) |
| Mar 30, 2023 | Buy | 0 | Brennan Kevin M. | |
| Jan 01, 2023 | Buy | 350 000 | Russo Rene | Stock Option (right to buy) |
| Jan 01, 2023 | Buy | 136 500 | Huber Martin H. Jr. | Stock Option (right to buy) |
| Jan 01, 2023 | Buy | 24 000 | English Edward C | Stock Option (right to buy) |
| Nov 09, 2022 | Buy | 20 200 | English Edward C | Stock Option (right to buy) |
| Nov 09, 2022 | Buy | 0 | English Edward C | Common Stock |
| Sep 15, 2022 | Buy | 0 | Heyman Tomas J. | |
| Sep 15, 2022 | Buy | 26 400 | Heyman Tomas J. | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 20 000 | Huber Martin H. Jr. | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 20 000 | Huber Martin H. Jr. | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Rossi Christina | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Rossi Christina | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Ross Michael Jay | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Ross Michael Jay | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Clancy Paul J | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Clancy Paul J | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Xu Yuan | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Bonstein Sara | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 13 200 | Bonstein Sara | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 26 400 | Ross Robert W. | Stock Option (right to buy) |
| Jun 15, 2022 | Buy | 0 | Ross Robert W. | |
| Feb 22, 2022 | Buy | 49 500 | Giovine Salvatore | Stock Option (right to buy) |
| Feb 22, 2022 | Buy | 65 000 | Huber Martin H. Jr. | Stock Option (right to buy) |
| Feb 22, 2022 | Buy | 150 000 | Russo Rene | Stock Option (right to buy) |
| Jan 04, 2022 | Buy | 26 400 | Xu Yuan | Stock Option (right to buy) |
| Jan 04, 2022 | Buy | 0 | Xu Yuan | |
| Dec 22, 2021 | Buy | 100 000 | Russo Rene | Stock Option (right to buy) |
| Dec 22, 2021 | Buy | 100 000 | Russo Rene | Stock Option (right to buy) |
| Dec 10, 2021 | Buy | 3 188 | Bain Capital Life Sciences Investors, Llc | Common Stock |
| Dec 10, 2021 | Buy | 21 812 | Bain Capital Life Sciences Investors, Llc | Common Stock |
| Dec 09, 2021 | Buy | 4 011 | Bain Capital Life Sciences Investors, Llc | Common Stock |
| Dec 08, 2021 | Buy | 13 458 | Bain Capital Life Sciences Investors, Llc | Common Stock |
| Oct 26, 2021 | Buy | 0 | Bain Capital Life Sciences Investors, Llc | Common Stock |
| Oct 26, 2021 | Buy | 312 500 | Sv7 Impact Medicine Fund Lp | Common Stock |
| Oct 26, 2021 | Buy | 302 588 | Sv7 Impact Medicine Fund Lp | Common Stock |
| Oct 26, 2021 | Buy | 998 544 | Sv7 Impact Medicine Fund Lp | Common Stock |
| Oct 26, 2021 | Sell | 9 486 166 | Sv7 Impact Medicine Fund Lp | Series B Convertible Preferred Stock |
| Oct 26, 2021 | Sell | 2 874 595 | Sv7 Impact Medicine Fund Lp | Series C Convertible Preferred Stock |
| Oct 26, 2021 | Buy | 387 500 | Flynn James E | Common Stock |
| Oct 26, 2021 | Buy | 756 472 | Flynn James E | Common Stock |
| Oct 26, 2021 | Sell | 7 186 489 | Flynn James E | Series C Preferred Stock |
| Oct 26, 2021 | Buy | 218 705 | Fil Ltd | Common Stock |
| Oct 26, 2021 | Sell | 2 077 698 | Fil Ltd | Series B Preferred Stock |
| Oct 26, 2021 | Buy | 28 703 | Fmr Llc | Common Stock |
| Oct 26, 2021 | Buy | 686 499 | Fmr Llc | Common Stock |
| Oct 26, 2021 | Buy | 789 473 | Fmr Llc | Common Stock |
| Oct 26, 2021 | Buy | 372 215 | Fmr Llc | Common Stock |
| Oct 26, 2021 | Buy | 4 465 | Fmr Llc | Common Stock |
| Oct 26, 2021 | Sell | 6 521 739 | Fmr Llc | Series A-1 Preferred Stock |
| Oct 26, 2021 | Sell | 42 421 | Fmr Llc | Series B Preferred Stock |
| Oct 26, 2021 | Sell | 7 500 000 | Fmr Llc | Series A Preferred Stock |
| Oct 26, 2021 | Buy | 302 588 | Sv7 Impact Medicine Fund Lp | Common Stock |
| Oct 26, 2021 | Buy | 998 544 | Sv7 Impact Medicine Fund Lp | Common Stock |
| Oct 26, 2021 | Sell | 2 874 595 | Sv7 Impact Medicine Fund Lp | Series C Convertible Preferred Stock |
| Oct 26, 2021 | Sell | 9 486 166 | Sv7 Impact Medicine Fund Lp | Series B Convertible Preferred Stock |
| Oct 26, 2021 | Buy | 1 475 121 | Takeda Pharmaceutical Co Ltd | Common Stock |
| Oct 26, 2021 | Buy | 1 475 121 | Takeda Pharmaceutical Co Ltd | Common Stock |
| Oct 26, 2021 | Sell | 1 248 180 | Takeda Pharmaceutical Co Ltd | Series B Preferred Stock |
| Oct 26, 2021 | Sell | 226 941 | Takeda Pharmaceutical Co Ltd | Series C Preferred Stock |
| Oct 26, 2021 | Sell | 1 248 180 | Takeda Pharmaceutical Co Ltd | Series B Preferred Stock |
| Oct 26, 2021 | Sell | 226 941 | Takeda Pharmaceutical Co Ltd | Series C Preferred Stock |
| INSIDER POWER |
|---|
| 99.292 |
| Last 100 transactions |
| Buy: 17 768 732 | Sell: 51 005 346 (Shares) |
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 99.292.
In total, the insiders bought 17 768 732 and sold 51 005 346 XLO shares in the last 100 trades.
